Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Jun 29, 2020	EFFECT	EFFECT	View HTML 9999999995-20-001584.pdf 9999999995-20-001584.rtf 9999999995-20-001584.xls
Jun 25, 2020	CORRESP	CORRESP	View HTML 0000320017-20-000053.pdf 0000320017-20-000053.rtf
Jun 25, 2020	UPLOAD	UPLOAD	View HTML 0000000000-20-005723.pdf 0000000000-20-005723.rtf
Jun 19, 2020	S-1	Registration statement for face-amount certificate companies	View HTML 0000320017-20-000050.pdf 0000320017-20-000050.rtf 0000320017-20-000050.xls
Jun 18, 2020	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-20-000046.pdf 0000320017-20-000046.rtf 0000320017-20-000046.xls
Jun 5, 2020	D	Notice of Exempt Offering of Securities	View HTML 0000320017-20-000042.pdf 0000320017-20-000042.rtf 0000320017-20-000042.xls
May 26, 2020	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-20-000039.pdf 0000320017-20-000039.rtf 0000320017-20-000039.xls
May 26, 2020	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0000320017-20-000041.pdf 0000320017-20-000041.rtf 0000320017-20-000041.xls
May 12, 2020	D	Notice of Exempt Offering of Securities	View HTML 0000320017-20-000037.pdf 0000320017-20-000037.rtf 0000320017-20-000037.xls
May 7, 2020	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-20-000035.pdf 0000320017-20-000035.rtf 0000320017-20-000035.xls